Skip to content

Switzerland and U.S. Strike Landmark Trade Deal, Shifting Pharma Production

Swiss exporters get relief as tariffs drop—but pharma’s future may lie across the Atlantic. Will this deal redefine global manufacturing? The agreement marks a turning point after years of heated negotiations and industry pushback.

In this picture we can see few clothes, lights, metal rods and carts, and also we can find fence.
In this picture we can see few clothes, lights, metal rods and carts, and also we can find fence.

Switzerland and U.S. Strike Landmark Trade Deal, Shifting Pharma Production

The Swiss Federal Council and U.S. Trade Representative Jamieson Greer have reached an agreement, leading to a significant shift in pharmaceutical manufacturing. The deal, announced on Friday, will see the industry increase production in the U.S., potentially reducing Swiss output in the future.

The agreement comes after intensive negotiations by Federal Councillor Guy Parmelin, who faced criticism from both the FDP and The Centre Party for the 15% U.S. tariff on Swiss goods, considered excessive. The tariffs, initially set at 39% by President Trump in August 2025, have been lowered to match EU levels following the deal.

The watchmaking, medical technology, machinery, electrical, and metal industries are expected to reap the most benefits from the reduced tariffs. The Swiss government has committed to lowering tariffs on American products and removing non-tariff barriers. This alignment is set to ease pressure on Swiss exporters to relocate production to the EU or the U.S. The deal covers sectors including pharmaceuticals, gold refining, and railway equipment.

The pharmaceutical industry's shift to U.S. manufacturing is a key aspect of the agreement. Switzerland has committed to relocating certain manufacturing processes to the United States and reducing its trade surplus with the U.S.

The agreement between Switzerland and the United States is expected to have a significant impact on various industries, with pharmaceutical manufacturing being one of the most affected. While the 15% tariff remains a point of contention, the deal is set to ease trade pressures and facilitate further negotiations between the two nations.

Read also:

Latest